von Kaisenberg Constantin, Kozlowski Peter, Kagan Karl-Oliver, Hoopmann Markus, Heling Kai-Sven, Chaoui Rabih, Klaritsch Philipp, Pertl Barbara, Burkhardt Tilo, Tercanli Sevgi, Frenzel Jochen, Mundlos Christine
Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Germany.
Praenatal-Medicine and Genetics Düsseldorf, MVZ Amedes für Pränatal-Medizin und Genetik GmbH, Düsseldorf, Germany.
Ultraschall Med. 2025 Feb;46(1):36-48. doi: 10.1055/a-2280-4756. Epub 2024 Oct 1.
This extensive AWMF 085-002 S2e-guideline "First Trimester Diagnosis and Therapy @ 11-13 Weeks of Gestation" has systematically analyzed high-quality studies and publications and the existing evidence (evidence tables) and produced recommendations (level of recommendation, level of evidence, strength of consensus).This guideline deals with the following topics in the context of the 11-13 weeks scan: the legal basis, screening for anatomical malformations, screening for chromosomal defects, quality assessment and audit, screening for preeclampsia and FGR, screening for preterm birth, screening for abnormally invasive placenta (AIP) and placenta accreta spectrum (PAS), screening for velamentous cord insertion and vasa praevia, screening for diabetes mellitus and LGA.Screening for complications of pregnancy can best be carried out @ 11-13+6 weeks of gestation. The issues of how to identify malformations, chromosomal abnormalities and certain disorders of placentation (high blood pressure and proteinuria, intrauterine growth retardation) have been solved. The problem of how to identify placenta percreta and vasa previa has been partially solved. What is still unsolved is how to identify disorders of glucose metabolism and preterm birth.In the first trimester, solutions to some of these problems are available: parents can be given extensive counselling and the risk that a pregnancy complication will manifest at a later stage can be delayed and reduced. This means that screening is critically important as it helps in decision-making about the best way to manage pregnancy complications (prevention and intervals between follow-up examinations).If no treatment is available and if a termination of pregnancy is considered, the intervention can be carried out with far lower complications compared to the second trimester of pregnancy. In most cases, further examinations are not required and the parents can be reassured. A repeat examination at around week 20 of gestation to complete the screening for malformations is recommended. NOTE:: The guideline will be published simultaneously in the official journals of both professional societies (i.e. Ultraschall in der Medizin/European Journal of Ultrasound for the DEGUM and Geburtshilfe und Frauenheilkunde for the DGGG).
这份内容广泛的德国医学专业协会(AWMF)085 - 002 S2e指南《孕11 - 13周的孕早期诊断与治疗》系统分析了高质量研究、出版物及现有证据(证据表),并给出了推荐意见(推荐等级、证据等级、共识强度)。本指南在孕11 - 13周超声检查背景下涉及以下主题:法律依据、解剖结构畸形筛查、染色体缺陷筛查、质量评估与审核、子痫前期及胎儿生长受限筛查、早产筛查、凶险性前置胎盘(AIP)及胎盘植入谱系(PAS)筛查、帆状脐带附着及前置血管筛查、糖尿病及大于胎龄儿筛查。妊娠并发症筛查最佳在孕11 - 13⁺⁶周进行。如何识别畸形、染色体异常及某些胎盘植入相关疾病(高血压和蛋白尿、胎儿生长受限)的问题已得到解决。如何识别穿透性胎盘植入和前置血管的问题已部分得到解决。尚未解决的是如何识别糖代谢紊乱和早产问题。在孕早期,其中一些问题有解决办法:可为父母提供全面咨询,可延缓并降低妊娠并发症在后期出现的风险。这意味着筛查至关重要,因为它有助于就管理妊娠并发症的最佳方式(预防及后续检查间隔)做出决策。如果没有可用的治疗方法且考虑终止妊娠,与孕中期相比,干预带来的并发症要低得多。在大多数情况下,无需进一步检查,可让父母放心。建议在妊娠约20周时重复检查以完成畸形筛查。注意:该指南将同时在两个专业协会的官方期刊上发表(即德国超声医学学会的《Ultraschall in der Medizin》/《欧洲超声杂志》以及德国妇产科学会的《Geburtshilfe und Frauenheilkunde》)。